Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E

about

Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E

Item

http://www.wikidata.org/entity/Q58801878

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@en

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@nl

type

Item

label

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@en

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@nl

prefLabel

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@en

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@nl

P1476

Activating Autophagy Enhanced ...... uximab-Monomethyl Auristatin E

@en

P2093

Dianwen Ju

http://www.w3.org/2001/XMLSchema#string

Jiajun Fan

http://www.w3.org/2001/XMLSchema#string

Jingyun Luan

http://www.w3.org/2001/XMLSchema#string

Qicheng Chen

http://www.w3.org/2001/XMLSchema#string

Shaofei Wang

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Xuyao Zhang

http://www.w3.org/2001/XMLSchema#string

Yanyang Nan

http://www.w3.org/2001/XMLSchema#string

Yichen Wang

http://www.w3.org/2001/XMLSchema#string

Youling Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia

Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death

Autophagy: renovation of cells and tissues

Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells.

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.

Cytotoxic autophagy in cancer therapy.

cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.

Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.

P304

1799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01799

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30123222

http://www.w3.org/2001/XMLSchema#string

P932

6085421

http://www.w3.org/2001/XMLSchema#string